News & blog

Drug discovery specialist backs start-up

Integrated drug discovery company Signature Discovery, based at Alderley Park’s BioHub in Cheshire, has invested in new start-up, Peak Proteins.

The investment, through its parent Sygil Group, is part of an ongoing strategy to build and expand the group’s capabilities.

The partnership with Peak Proteins adds protein production and crystallography to Sygnature’s current range of drug discovery capabilities.

Read more